Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies - Test2 - elhamkhani - TriplyDB

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

http://www.wikidata.org/entity/Q24802579

about

Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis Survivin: a unique target for tumor therapy Survivin: A molecular biomarker in cancer Survivin-derived peptide epitopes and their role for induction of antitumor immunity in hematological malignancies Survivin as a target for new anticancer interventions Targeting survivin in cancer therapy Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer Assessment of mRNA splice variants by qRT-PCR.The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.Association of survivin splice variants with prognosis and treatment of breast cancer.Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR.Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin MicroRNA regulation and therapeutic targeting of survivin in cancer.Silencing survivin splice variant 2B leads to antitumor activity in taxane--resistant ovarian cancer Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis Evaluation of survivin splice variants in pituitary tumors.Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes.The role of survivin in diagnosis, prognosis and treatment of breast cancer.Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.Survivin study: an update of "what is the next wave"?Suppressed diversity of survivin splicing in active rheumatoid arthritis.Relation between expression pattern of p53 and survivin in cutaneous basal cell carcinomas.Transcriptional and post-transcriptional controls of survivin in cancer cells: novel approaches for cancer treatment.Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.Survivin multifaceted activity in head and neck carcinoma: current evidence and future therapeutic challenges.Survivin: a target from brain cancer to neurodegenerative disease.Survivin in skin pathologies.Survivin in solid tumors: rationale for development of inhibitors.Clinico-pathologic relevance of Survivin splice variant expression in cancer Relationship of survivin to clinical drug resistance in Burkitt's lymphoma of the head and neck region.Survivin splice variants and their diagnostic significance.Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α.Efficient induction of specific cytotoxic T lymphocytes against gastric adenocarcinoma by a survivin peptide.An integrated PCR microfluidic chip incorporating aseptic electrochemical cell lysis and capillary electrophoresis amperometric DNA detection for rapid and quantitative genetic analysis.Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant, and platinum-based drugs.Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin.

P2860

Q24295217-BB555F79-DF19-424F-8D70-7CA184017F18 Q26747332-84E40092-CC8A-4796-AE97-E2BB8B32A766 Q26823439-62710230-49E9-4315-A709-B0A9C0CD89D1 Q28251858-320B4338-A56D-41B1-9CDE-C30122A1A3F8 Q28257235-B9CB3946-A1E4-44E0-B254-49077B3212E7 Q28273083-67BE6835-A88E-4408-80E2-009A6881A380 Q28306223-0DC42F51-E546-469E-8BB5-ABEEFCDA5655 Q33765915-6731BA03-708D-4CDD-9573-A06061A4976A Q34195072-26DC354A-424E-4166-9AD8-9AD266A78D54 Q34299904-DCEA7450-EA86-4977-B0B7-4D543E8360BD Q34657717-94DDCF13-FA34-4A49-BC6E-FAF0AFD0C398 Q34757482-D2D6FC6C-9D31-46C1-94CB-47E7FDB1F2F2 Q34871780-F3E1159C-8D61-4DC0-8521-3785BF89EE42 Q34991312-EE3DACC5-FEF3-4A16-A845-5C0E5A12690F Q35024933-2757B287-4B34-4DB2-A3AE-0923F8F1F542 Q35119245-774D60FF-4631-4FA2-BBD3-0AC933B9566A Q35582889-AD8E1248-08F2-4FE8-B70D-1419773A3B16 Q35628857-8110BFCB-9BFC-4792-B61A-372E778E5B39 Q35635793-DD32AC9D-DD90-4299-B4F3-C95E478ABB6B Q35667653-6D5CAFCA-CA6D-4111-9A04-6DCC1CB2A385 Q35668616-BDDF3CC8-E20C-4F02-9D4D-1F7CE9941420 Q36430244-DD0148FF-500A-4AB3-9B6B-CD19AC68E5EA Q36433351-D29AED53-2D98-4607-93B9-369819868D77 Q36473904-3BEEEDA6-7360-454B-AC91-8337271DFC98 Q36682871-BF805E96-BE75-4AD2-AA6B-41D7E2C4B5ED Q36930279-A7D96290-A69C-40B1-9D96-9AC35BB13193 Q36963631-E31B7C04-E247-451C-B3F8-1A754016AFC7 Q37064709-03A25B0B-5D2B-45B1-8361-6200733B4526 Q37424024-55F7C880-741F-47CD-9F6F-EE1A5E6FF617 Q37798272-0EC1C983-D3D9-4572-9A82-92F68A56C4F5 Q37876468-6433EA50-E2A0-4190-BB79-C0AEA8FC3080 Q37974867-31B06735-D6F7-460E-86EE-9353E2451D5F Q38116267-8179B06B-5351-463E-9C6C-D7D3C368191E Q38416237-D872CF64-1FF6-4CF5-8A1D-9E9AC6EA11EA Q38561421-484845C9-9F67-4C21-98D8-255D3F609CD5 Q38738898-C9D725EE-85EF-4B6B-BD98-FE28E6D4606A Q39275796-8484DE1E-30C8-412E-8B13-47CCCA019495 Q39282920-6BC212FE-028E-42CC-9559-DB7176A7BBC9 Q39697634-E7AD529C-F2DE-40D2-96D4-CF62D28F1798 Q40061181-C8EC9EFE-A70F-474D-9EAE-ECC17C67AE24

P2860

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

http://www.wikidata.org/entity/Q24802579

description

2005 nî lūn-bûn

@nan

2005 թուականին հրատարակուած գիտական յօդուած

@hyw

2005 թվականին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@ast

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@en

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@nl

type

label

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@ast

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@en

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@nl

prefLabel

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@ast

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@en

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@nl

P1433

Q24802579-21304F71-600C-4580-9CCA-55977387B09A

P1476

Q24802579-086EF2DE-E5D1-449D-9164-B1B347323D7E

P2093

Q24802579-03AD3CCE-726D-427B-88DD-788FE0121088

Q24802579-901D2D20-22D7-4249-986E-515C2792283A

Q24802579-EFDF5CFD-9676-493E-9A92-6387E43470FB

P2860

Q24802579-152D010F-7CFB-49DB-ACCA-7B206F12B59D

Q24802579-15AAF75A-75F5-4678-80F2-4BC858CE50AB

Q24802579-287A5C88-F32D-4237-9E77-9B5674A72040

Q24802579-29552B1C-0344-40A0-8CA4-ADCDA8AD9204

Q24802579-4391EF91-63F6-4D7E-9A01-607B3E6FADEE

Q24802579-47655B70-CE9A-4FC2-A50C-7EB3AED84F8C

Q24802579-4CB0540A-3FD1-4073-BC28-90C0E8B80072

Q24802579-523D5137-1BC8-4415-A4B2-CC04BE5DEB07

Q24802579-5F8A40C5-F6DB-4028-838B-073378DE71CC

Q24802579-69187603-C71E-46FE-8870-132CD31F54F4

P2888

Q24802579-1DCC38C2-15E6-46BC-A478-DD2A11D64DBD

P304

Q24802579-BDA936D2-0AC7-42E2-9670-63FA71604902

P31

Q24802579-5379C537-C648-49A1-B21C-000D0E20758E

P3181

Q24802579-0080E246-11FA-464B-9EE3-499156B6D2F3

P356

Q24802579-B9421DC8-11CC-49D0-8921-9E2D89F59916

P407

Q24802579-CEB63B34-C0FA-4F39-8906-06B42A069B2A

P433

Q24802579-41DE81DE-D446-4572-9B51-AB7480B2F2C0

P478

Q24802579-BEFF0518-1821-4E9E-8182-4A15B4009000

P577

Q24802579-6DC88556-7F2A-4F2F-987D-7AE476250632

P5875

Q24802579-53B944D4-AD5E-4DD2-A2A7-E98902C6450B

P6179

Q24802579-B18856D4-5FA9-4EB4-A6EF-086EF1406383

P698

Q24802579-658BC5CF-DCCA-4FC0-91C7-6CA7884C54AF

P932

Q24802579-1E8A67C8-8C8A-48A8-94E9-133270DD29B0

P3181

P356

P1433

Molecular Cancer

P1476

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

@en

P2093

Hugo Caldas

http://www.w3.org/2001/XMLSchema#string

Laura E Honsey

http://www.w3.org/2001/XMLSchema#string

Rachel A Altura

http://www.w3.org/2001/XMLSchema#string

P2860

Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties

Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin

The complex life of WT1

Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

The complex life of WT1

Human survivin is a kinetochore-associated passenger protein.

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis.

Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.

P2888

P304

11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

525313

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-4598-4-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7989616

http://www.w3.org/2001/XMLSchema#string

P6179

1028902283

http://www.w3.org/2001/XMLSchema#string

P698

15743529

http://www.w3.org/2001/XMLSchema#string

P932

554981

http://www.w3.org/2001/XMLSchema#string